WillScot's 2024 Financials Set the Stage for 2025 Outlook

Published 21 hours agoWSC

WillScot's 2024 Financials Set the Stage for 2025 Outlook

As of May 2, 2025, WillScot has not released its financial performance for the first quarter of 2025. The most recent financial update comes from their fourth quarter and full-year 2024 results, shared on February 20, 2025, on Nasdaq.

For the full year 2024, WillScot reported a revenue of $2,396 million and an adjusted EBITDA of $1,063 million. They achieved an adjusted EBITDA margin of 44.4%. Adjusted income from continuing operations was $310 million, with an adjusted diluted earnings per share of $1.63. The company generated $562 million in net cash from operating activities and had an adjusted free cash flow of $554 million. Additionally, WillScot repurchased 7.1 million shares for $270 million, showing a return on invested capital of 16.7%.

Looking ahead to 2025, WillScot has projected its revenue to range between $2,275 million and $2,475 million, with an adjusted EBITDA expectation of $1,000 million to $1,090 million. They plan capital expenditures between $225 million and $305 million and have started a quarterly cash dividend program at $0.07 per share. As broad trends indicate, the company aims to sustain growth through higher average monthly rates and enhanced product offerings. Reuters highlighted these strategic moves as preparation to navigate anticipated market challenges.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Select Medical Projects Revenue Surge with New Rehabilitation Facilities

Select Medical Projects Revenue Surge with New Rehabilitation Facilities

3 minutes agoSEM

Select Medical Corporation has set an ambitious revenue target of between $5.3 billion and $5.5 billion for 2025, driven by its aggressive expansion into inpatient rehabilitation services. A major part of this growth strategy is the opening of several new facilities across the United States, such as a sizable hospital in Temple, Texas, scheduled for late Q1 2025. This facility alone will add over 40 beds, boosting access to rehabilitation care in Central Texas. Key developments in support of this expansion include a planned joint venture with CoxHealth to establish a new inpatient rehabilitation hospital in Southwest Missouri, set to open in Q4 2025, pending approval. Additionally, a 50-bed facility in Oklahoma City is poised to commence operations in December 2024, in collaboration with SSM Health. Select Medical also aims to expand in Pennsylvania with a new 20-bed facility expected in Q2 2025, in partnership with UPMC. These moves are part of Select Medical's broader strategy to add a total of 569 beds through 2026, aiming to significantly boost revenue and improve adjusted EBITDA. Meanwhile, according to recent stock market data, Select Medical Holdings Corporation is valued at $14.26, experiencing a slight drop of $3.98 or 0.22%. The latest trading figures report an intraday volume of 4,344,695 and price fluctuations between a high of $18.20 and a low of $14.04, as noted by Reuters.

Mohawk Industries Faces $50 Million Tariff Impact, Adjusts Strategy

Mohawk Industries Faces $50 Million Tariff Impact, Adjusts Strategy

Mohawk Industries has provided an update on its financial performance and projections, revealing a significant $50 million hit from tariffs that will affect its financial results. Amid these challenges, the company also shared its second-quarter earnings figures. Mohawk reported net earnings of $101 million with diluted earnings per share (EPS) of $1.58. When adjusted for specific charges, net earnings were $176 million and EPS was $2.76. Looking ahead, Mohawk has offered guidance for the third quarter, projecting an EPS range of $2.58 to $2.68, excluding any one-time charges. Additionally, the company is undertaking restructuring efforts aimed at saving $100 million annually, though these will incur a total cost of about $130 million. Moves include idling some operations and consolidating warehouses to streamline efforts and cut costs as Reuters noted recently. In response to the challenging U.S. flooring market, marked by lower demand and excess inventory due to pre-tariff purchases, Mohawk Industries is focusing on increasing sales volume and reducing operating costs. These strategic shifts are part of the company’s efforts to mitigate tariff impacts and adapt to changing market dynamics.

DiamondRock Hospitality Revises 2025 Revenue Projections

DiamondRock Hospitality Revises 2025 Revenue Projections

DiamondRock Hospitality Company has adjusted its 2025 financial outlook, specifically revising its guided Revenue per Available Room (RevPAR) growth. The company now projects RevPAR to vary between a 1% decrease and a 1% increase, a shift from earlier expectations of 1% to 3% growth. Supporting this updated forecast, DiamondRock estimates its Adjusted EBITDA to be between $275 million and $300 million, while Adjusted Funds from Operations (FFO) are predicted to range from $199 million to $224 million, which translates to $0.94 to $1.06 per share. Part of the company’s strategy involves selling non-core hotels to reinvest in higher-return opportunities, aiming to bolster earnings per share. Additionally, the company forecasts stronger travel demand for 2025, planning to enhance group demand and operational effectiveness in urban areas. As part of its fiscal strategy, DiamondRock has declared a $0.08 per share quarterly cash dividend for the first quarter of 2025. According to Reuters, the hotel company emphasizes these measures are designed to better align with current market conditions and enhance overall portfolio performance.

ARK Invest Alters Holdings with Moves in Palantir and Roku Stock

ARK Invest Alters Holdings with Moves in Palantir and Roku Stock

4 hours agoROKU

Cathie Wood's ARK Invest has been making strategic tweaks to its portfolio, notably shedding shares of Palantir Technologies and Roku recently. On February 10, 2025, ARK's main fund, ARKK, sold 135,775 shares of Palantir, netting around $15.05 million. Additionally, ARK sold 78,654 shares of Roku, translating to about $6.69 million. This is not ARK’s first adjustment involving Roku in recent months. Back on October 31, 2024, ARK took a bullish stance by purchasing 308,892 shares of Roku across three funds, for a total of nearly $23.94 million. However, shifts in strategy were already apparent earlier, as evidenced by a sale of 9,547 Roku shares from the ARKW ETF on September 27, 2024, worth approximately $703,613. These transactions illustrate ARK's agility in managing its investments to align with evolving market dynamics. As Reuters reported, such strategic moves are indicative of a responsive investment approach by ARK, adapting its holdings to reflect both the broader market environment and the performance of individual companies.